Since FOXM1 acts as a transcription factor in the nucleus to regulate ESR1 transactivation, we detected the expression level of FOXM1 and ER-α in the nucleus upon AD treatment and found that FOXM1 and ER-α were significantly decreased in the nucleus (Figure 4E). Here, ESR1 is linked to Alzheimer disease.